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Organismal aging is accompanied by a general 
decline in many tissues and organs. With few 
exceptions, specialized cells in the body have   
a limited lifespan, and therefore tissues must 
be  maintained  and  regenerated  by  resident   
tissue-specific stem cells. By extension, much 
of the age-related decline in tissue function 
and related pathologies may be attributed to 
changes  in  these  stem  cell  pools  over  time. 
Stem cell aging likely involves genetic muta-
tions  and  alterations  at  the  epigenetic  and 
protein levels in the stem cells themselves, in 
combination with changes in the aged micro-
environment in which the stem cells reside. 
The  relative  contributions  of  each  of  these 
factors continue to be important areas of re-
search and debate (Liu and Rando, 2011). A 
more complete understanding of the biology 
and mechanisms of stem cell aging could en-
able targeted treatment strategies aimed to re-
duce or even reverse the aging process at the 
stem cell level as a strategy to combat aging 
and age-related pathologies.
The murine hematopoietic system is prob-
ably the best-studied model of mammalian 
stem cell aging. It has long been appreciated 
that the hematopoietic stem cell (HSC) activity 
of BM cells from young and old mice is differ-
ent. Transplants of old BM were shown to out-
perform the same number of cells from young 
mice (Harrison, 1983), and this was later deter-
mined to be caused by an age-related increase 
in  the  concentration  of  HSCs  in  the  BM 
(Harrison et al., 1989). The advent of flow cytom-
etry and subsequent discovery of cell surface 
markers  that  enrich  for  functionally  defined 
HSCs soon led to the realization that the size of 
the stem cell pool, as defined by any of a vari-
ety of marker combinations, increases dramati-
cally with age (Morrison et al., 1996; Sudo et al., 
2000; Rossi et al., 2007b). However, although 
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Hematopoietic stem cell (HSC) populations change with aging, but the extent to which this 
is caused by qualitative versus quantitative alterations in HSC subtypes is unclear. Using 
clonal assays, in this study we show that the aging HSC compartment undergoes both 
quantitative and qualitative changes. We observed a variable increase of HSC pool size with 
age, accompanied by the accumulation of predominantly myeloid-biased HSCs that regen-
erate substantially fewer mature progeny than young myeloid-biased HSCs and exhibit 
reduced self-renewal activity as measured by long-term secondary transplantation. Old 
HSCs had a twofold reduction in marrow-homing efficiency and a similar decrease in 
functional frequency as measured using long-term transplantation assays. Similarly, old 
HSCs had a twofold reduced seeding efficiency and a significantly delayed proliferative 
response compared with young HSCs in long-term stromal cell co-cultures but were indis-
tinguishable in suspension cultures. We show that these functional defects are characteris-
tics of most or all old HSCs and are not indicative of a nonfunctional subset of cells that 
express HSC markers. Furthermore, we demonstrate that cells with functional properties of 
old HSCs can be generated directly from young HSCs by extended serial transplantation, 
which is consistent with the possibility that they arise through a process of cellular aging.
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Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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limiting  dilutions  of  unseparated  or  lineage-depleted  BM 
cells (Cho et al., 2008), it was determined that the relative 
proportion of myeloid-dominant HSCs increases with age 
and that myeloid-dominant HSCs from both young and old 
mice show a blunted IL-7 response. More recently, Beerman 
et al. (2010a) reported that myeloid-dominant HSCs were 
enriched in the CD150hi population of LSK CD34flt3 BM 
and that the size of this population increased dramatically 
with age. Furthermore, when populations of purified CD150-
matched HSCs from old and young donors were compared 
in primary and secondary competitive transplants, a significant 
decrease in the output of mature cells from old HSCs was 
observed (Beerman et al., 2010a). However, because a com-
prehensive analysis of the functional properties of individual 
old and young HSCs is lacking, the identity of any functional 
changes in individual old HSCs remains elusive.
In this study, we set out to obtain a more complete and 
high-resolution understanding of the aging HSC pool. To do 
this, we designed a series of experiments to evaluate multiple 
properties of purified HSCs isolated from the BM of young 
and old mice. Collectively, our analyses reveal that a popula-
tion of predominantly myeloid-dominant HSCs accumulates 
with age and that individual old HSCs are functionally infe-
rior to their young counterparts in multiple parameters, in-
cluding a lower functional frequency in vitro and in vivo, a 
delayed proliferation response in stromal co-cultures, a re-
duced efficiency for short-term BM homing, production of 
smaller clones of mature cells in transplanted recipients, and a 
reduced long-term in vivo self-renewal activity. Furthermore, 
we  present  evidence  that  in  vivo  repopulating  cells  with 
characteristics of aged HSCs can be generated from young 
HSCs over a prolonged course of a serial transplantation sim-
ilar in duration to the lifespan of a mouse.
RESULTS
The frequency of BM cells with HSC markers increases 
dramatically with age but is highly variable between 
individual old mice
The overall proportion of BM cells expressing HSC-associated 
cell surface markers has been reported to increase with   
age in the mouse (Dykstra and de Haan, 2008). To confirm   
this, we stained BM from 10 young (4–5 mo old) and 22 
old (24–28 mo old) C57BL/6 (B6) mice with a panel of   
HSC  markers  (Fig.  1  A).  Consistent  with  earlier  studies 
(Morrison  et  al.,  1996;  Sudo  et  al.,  2000;  Rossi  et  al., 
2007b),  the  median  proportion  of  LinloSca1+cKit+  (LSK) 
cells within the BM increased 1.9-fold in old mice (Fig. 1 B), 
and  the  proportion  of  CD48CD34EPCR+CD150+ 
(4834E+150+) cells within the LSK increased a further 
4.6-fold (Fig. 1 C). Collectively, we observed a mean 12-fold 
increase in the frequency of LSK4834E+150+ cells in 
old mice (Fig. 1 D). However, although the frequency of 
BM cells with HSC markers was similar in all young mice 
(i.e.,  75–100  cells  per  million),  these  frequencies  were 
highly  variable  between  old  individuals,  ranging  from   
100 to 4,300 LSK4834E+150+ cells per million viable 
a similar proportion of these cells purified from old or young 
mice were functional when measured in vitro, a markedly 
reduced frequency of purified cells from old mice was deemed 
to be functional HSCs when measured in long-term trans-
plantation assays (Morrison et al., 1996; Sudo et al., 2000). 
These observations led to two early hypotheses; namely, that 
the pool of cells expressing HSC-associated markers is con-
taminated with primitive progenitors that are detected by 
in vitro assays but lack repopulating ability in vivo (Sudo et al., 
2000) or that HSCs from old mice have a homing and/or en-
graftment defect and therefore remain undetected (Morrison   
et al., 1996). The former hypothesis is supported by observa-
tions  of  improved  functional  frequencies  when  alternate 
marker combinations are used to purify old HSCs (Yilmaz 
et al., 2006). Support for the latter is provided by a study of 
short-term HSC homing that reported a twofold lower abil-
ity of functionally defined HSCs from old mice to home to 
the BM or spleen within a 24 h period (Liang et al., 2005). In 
addition, there is now strong evidence of age-related differ-
ences in the properties of HSCs that do engraft in vivo 
(Dykstra and de Haan, 2008). The best characterized of these 
differences is that upon transplantation; old HSCs tend to 
have a myeloid-skewed blood cell production caused by a 
decreased  ability  to  produce  lymphoid  cells  (Sudo  et  al., 
2000; Kim et al., 2003; Liang et al., 2005; Rossi et al., 2005; 
Cho et al., 2008; Beerman et al., 2010a).
Functional changes occurring in the HSC pool with age 
have been commonly attributed to cellular aging. According 
to this model, the functional properties of individual HSCs 
gradually decline as the result of an accumulation of cellular 
damage such as the accrual of DNA lesions (Rossi et al., 
2007a; Mohrin et al., 2010; Yahata et al., 2011) or epigenetic 
dysregulation (Bennett-Baker et al., 2003; Chambers et al., 
2007). However, the identification of separate populations of 
intrinsically lineage-biased HSCs (Müller-Sieburg et al., 2002; 
Dykstra et al., 2007) has suggested a different model in which 
the clonal composition of the HSC pool, rather than individ-
ual HSCs, changes with age. Specifically, myeloid-dominant 
HSCs are thought to accumulate in the old HSC pool at the 
expense of lymphoid-dominant and lineage-balanced HSCs 
(Cho  et  al.,  2008;  Muller-Sieburg  and  Sieburg,  2008; 
Beerman et al., 2010a; Challen et al., 2010). In this latter model, 
individual HSCs from old mice are thought to be function-
ally equivalent to their lineage-biased counterparts in young 
mice, and as such, age-associated differences in the function 
of the HSC compartment are thought to be caused exclu-
sively by the relative increase in myeloid-dominant HSCs. 
(Cho et al., 2008; Muller-Sieburg and Sieburg, 2008; Challen 
et al., 2010). Although these models are not mutually exclusive, 
determining their respective significance is a vital step toward a 
complete understanding of the underlying mechanisms.
Resolution of these issues has to date been confounded 
by difficulties in interpreting the results of assays of bulk pop-
ulations of old and young HSCs, which preclude assessments 
of heterogeneity within these HSC compartments. In a recent 
study in which clonal analysis was performed by transplanting JEM Vol. 208, No. 13 
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exposed to high levels of mitogenic cyto-
kines, virtually all single cells of the sorted 
populations exhibited a considerable proliferative response.
Next, we compared the clonogenic efficiency of purified 
cells using a complementary in vitro assay that is closer to 
physiological conditions in that it relies on stromal feeder 
cells without the addition of recombinant cytokines. Sin-
gle purified cells were sorted onto preestablished FBMD-1 
(Flask BM Dexter-1; FBMD) stromal feeder layers and were 
scored for their ability to generate characteristic “cobble-
stone” colonies at any point on or after day 7. The propor-
tion of single cells thus classified as cobblestone area–forming 
cells (CAFC [CAFCd7+]) was found to be almost twofold 
lower in old compared with young LSK4834E+150+ cells 
(Fig. 2 B, left bars). Of interest, this defect appeared to be 
specific to the cells with HSC-associated markers because 
no  difference  in  CAFC  frequency  in  LSK48+150  cells 
(which contain hematopoietic progenitors but no HSC ac-
tivity) from young and old mice was detected (Fig. 2 B, right 
bars). Consistent with this, a similar analysis of LSK48150+ 
cells, which contain CD34+ and EPCR cells in addition   
to LSK4834E+150+ cells, demonstrated an intermediate 
(1.5-fold) decrease in CAFC frequency with age (Fig. 2 B, 
middle bars).
It  is  important  to  note  that  the  proportion  of  old 
LSK4834E+150+ cells that were functional as measured in 
this CAFC assay had no correlation with their frequency in 
individual old mice (Fig. 2 C). This indicates that the increased 
variation in the primitive cell pool size observed in old mice 
is independent of the accompanying functional decline in the 
BM cells. Therefore, young mice exhibit strict control of the 
LSK4834E+150+ pool size, whereas in old mice this is 
much less evident.
Old LSK4834E+150+ cells have reduced clonogenic 
efficiency in stromal co-cultures but not in liquid cultures
Together with the dramatic increase in cells with HSC markers 
in old BM, it is also well established that this population has, on 
average, a reduced function per cell compared with young cells 
with the same marker combination (Beerman et al., 2010b). 
However, a full understanding of this phenomenon requires 
analysis of individual HSCs. For example, old cells with 
HSC markers might all have a similar but reduced function 
compared with their young counterparts. Alternatively, this 
population of cells in old mice might simply reflect the pres-
ence in the sorted population of functionally unrelated cells 
that express the same combination of surface molecules. To ad-
dress this, we first compared at a clonal level the proliferative 
response of various purified cell populations from young and 
old mice in stromal cell–containing and stroma-free cultures.
When single cells were seeded in stroma-free cytokine-
supplemented cultures, 90% of LSK4834E+150+ cells and 
80% of LSK48150+ cells demonstrated extensive prolif-
erative potential in response to stem cell factor plus IL-11, 
regardless of the age of the mouse from which they had been 
obtained (Fig. 2 A). This indicates that the phenotypically 
defined HSC compartment in old mice is not contaminated 
with cells that are completely nonfunctional. Indeed, when 
Figure 1.  The frequency of BM cells with 
HSC markers increases with age but is highly 
variable between individual old mice.  
(A) Representative FACS profiles of BM from 
young and old mice. BM from a young (4 mo) and 
an old (28 mo) mouse was collected and stained 
with antibodies specific for HSC markers as de-
scribed in Materials and methods. Equal numbers 
of events (4.5 × 105) are shown for each mouse. 
Viable cells were first selected based on their 
forward and side scatter properties and their 
exclusion of propidium iodide. Lineage-low (Linlo) 
cells were then selected as shown in the leftmost 
panel, followed by gating for cells double positive 
for Sca1 and cKit to identify the LSK population. 
The LSK population was enriched further by se-
lecting those cells negative for CD34 and CD48 and 
positive for EPCR (E+) and CD150 to obtain the stem 
cell–enriched LSK4834E+150+ population.  
(B and C) Percentage of LinloSca1+cKit+ (LSK) in  
BM and percentage of CD48CD34EPCR+CD150+ 
within the LSK population of 10 individual young 
(4–5 mo) and 22 old (24–28 mo) mice. Dots repre-
sent individual mice, and horizontal lines indicate 
median values. (D) Mean BM frequencies of 
LSK4834E+150+ cells in the same 10 young 
and 22 old mice.2694 Functional defects of aged murine HSCs | Dykstra et al.
(Ploemacher et al., 1991; Neben et al., 1993). Because each 
culture was initiated with a single purified cell, we could 
measure  the  commencement  and  duration  of  cobblestone 
ability at a clonal level. In the experiments described here, we 
considered the ability to generate cobblestones at day 35 or 
later (CAFCd35+) as a surrogate measurement for HSC activity. 
To confirm the utility of this measurement, we sorted three 
LSK  subpopulations  from  young  BM:  LSK4834E+150+, 
LSK4834+150, and LSK48+34+150, which are known to 
contain HSCs, more primitive multipotent progenitors (MPPs), 
and less primitive MPPs, respectively (Wilson et al., 2008). 
When single cells of these phenotypes were measured using 
the CAFC assay, clear differences in the timing of cobble-
stone generation were observed, with CAFCd35+ activity 
restricted  almost  entirely  to  the  most  primitive  LSK48 
34E+150+ cells (Fig. 2 D).
60 LSK4834E+150+ cells from each of 9 young and 19 
old mice were individually seeded onto preestablished stro-
mal layers and scored weekly for cobblestone activity for up 
stem  cell  pool.  Considering  the  wide  range  in  LSK48 
34E+150+  cell  frequency  between  individual  old  mice 
(Fig. 1 D), this reveals that the size of the functional HSC 
pool can vary almost 50-fold between genetically identical 
mice of advanced age.
Reduced frequency and delayed proliferation response  
of CAFC day 35+ in LSK4834E+150+ population  
from old BM
We then compared the frequency and properties of functional 
HSCs within young and old LSK4834E+150+ cells using 
an in vitro assay for HSC activity. In the FBMD stromal co-
cultures just described, the timing of cobblestone generation 
corresponds  to  the  primitive  status  of  the  initiating  cell 
(Breems et al., 1994; de Haan et al., 1997). For example, day 7–10 
CAFC (CAFCd7-10) activity overlaps with hematopoietic 
progenitors  as  measured  by  early  spleen  colony–forming 
ability, whereas CAFCd28-35 activity overlaps with HSC activ-
ity as measured by long-term in vivo repopulation assays 
Figure 2.  Old and young BM cells with HSC 
markers have similar clonogenic ability in liquid 
culture but have reduced activity in stromal co-
cultures. (A) 60–120 purified LinloSca1+cKit+CD48
CD34EPCR+CD150+ (LSK4834E+150+) and 
LSK48150+ cells from each of five young or six old 
mice were seeded individually as single cells into 
liquid cultures supplemented with stem cell factor 
and IL-11. Shown is the mean proportion of single 
purified cells from the individually tested young and 
old mice that generated clones of at least 5,000 cells 
within 2 wk of culture. (B) 60–120 purified 
LSK4834E+150+, LSK48150+, and LSK48+150 
cells from young or old mice were seeded as single 
cells onto FBMD stroma and scored weekly for the 
presence or absence of cobblestone areas. Shown is 
the mean proportion of single purified cells from 
individually tested young (n = 7–9) and old (n = 12–20) 
mice that generated cobblestone areas at day 7 or 
later (CAFCd7+). (C) Dots represent individual 
young (n = 9) or old (n = 19) mice and show the size 
of the LSK4834E+150+ pool (as described in Fig. 1) 
and the clonogenic efficiency in stromal co-culture (as 
shown in B). (D) LSK4834E+150+ (HSC containing), 
LSK4834+150 (more primitive MPPs), and 
LSK48+34+150 (less primitive MPPs) were isolated 
from young BM and seeded individually onto FBMD 
stroma and scored weekly for the presence or absence 
of cobblestone areas, which are characteristic of 
proliferating primitive cells. Data represent a minimum 
of 500 wells per cell type from a total of 10 individual 
young mice. (E) 60 purified LSK4834E+150+ cells 
from each of 9 young and 19 old mice were seeded 
individually as single cells onto FBMD stroma and 
scored weekly for 11–13 wk for the presence or absence 
of cobblestone areas. Shown is the mean proportion 
of single purified LSK4834E+150+ cells from the individually tested young and old mice that generated cobblestone areas at any time point day 35 or 
later (CAFCd35+). (F) Proportion of LSK4834E+150+ cells with CAFCd35+ activity (described in E) that first generated cobblestone areas at the specified 
time after seeding. P < 0.001 for old (n = 187) versus young (n = 149) CAFCd35+, Mann-Whitney U test. Error bars on all panels represent 95% 
confidence intervals of the mean. ***, P < 0.001, unpaired two-tailed Student’s t test.JEM Vol. 208, No. 13 
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irradiated recipients. 16–21 h later, the recipients were sacri-
ficed, and the ratio of fluorescent cells obtained from the 
BM was compared with the ratio in which they were in-
jected (Fig. 4 A). This approach allowed the relative homing 
efficiency of young and old cells to be measured directly, 
that is, in the same recipient. The results clearly showed that 
the short-term marrow-homing efficiency of old LSK48150+ 
was reduced almost twofold compared with the coinjected 
young LSK48150+ cells (Fig. 4 B).
Defective in vivo homing and reduced growth  
on stromal cells in vitro are not shared features  
of old LSK48150+ cells
The similar magnitudes of the in vivo homing defect and re-
duction in CAFC efficiency suggested that these properties 
might be associated. Specifically, we hypothesized that there 
might be a subset of cells in old mice that express HSC mark-
ers (Fig. 1) and can proliferate in response to high levels of 
recombinant cytokines (Fig. 2 A) but are functionally defi-
cient, both in short-term homing (Fig. 4 B) and in response 
to stromal co-culture (Fig. 2 B). To determine whether the 
LSK48150+ cells with homing defects are the same as those 
that lack CAFC activity in stromal co-cultures, we compared 
the CAFCd7+ efficiency of old and young cells isolated be-
fore and after homing. However, this analysis revealed no 
functional improvement in homed old LSK48150+ cells as 
compared with young LSK48150+ cells (Fig. 4 C), suggest-
ing that the poor homing of the old cells and poor growth in 
stromal co-cultures are nonoverlapping features of the same 
cells. Thus, there does not appear to be a contaminating sub-
fraction within the old LSK48150+ population that is com-
pletely nonfunctional. Rather, this observation is consistent 
with the notion that these two functional defects are ran-
domly distributed across the old HSC pool or that they may 
be general characteristics of all old HSCs.
LSK4834E+150+ BM cells from old mice contain  
an increased proportion of myeloid-dominant HSCs  
with a lower output of mature blood cells per HSC
We next compared the functional characteristics of individual 
young  and  old  HSCs  upon  transplantation  into  irradiated 
hosts. To do this, we began with the set of 111 positive re-
cipients that were transplanted at limiting dilution with five 
old or young LSK4834E+150+ cells and performed self-
renewal, lineage distribution, and blood cell output measure-
ments in primary, secondary, and tertiary transplanted mice, 
as shown schematically in Fig. 3 A. As a strict measure for 
long-term, active hematopoiesis, we considered a mouse to 
be transplanted with an HSC only if there was a minimum 
1% donor contribution to the short-lived (Pillay et al., 2010) 
granulocyte population (defined as Gr-1+SSChi) at 24 wk 
after transplant. This is a more stringent definition than is 
normally applied and would be expected to exclude virtually 
all  clones  in  which  robust  self-renewal  had  not  occurred 
(Dykstra et al., 2007; Kent et al., 2009). At the same time, we 
did not stipulate minimum levels of donor-derived lymphoid 
to 13 wk. Of interest, out of >3,000 individual young and 
old LSK4834E+150+ and LSK48150+ cells tested, cob-
blestone activity was never observed to disappear one week 
and  reappear  at  a  later  week.  The  frequency  of  LSK48 
34E+150+ cells that generated cobblestones at day 35 or 
later (CAFCd35+) was found to be 1.9-fold lower in old 
than young mice (Fig. 2 E). Furthermore, the CAFCd35+ 
cells from young and old mice also exhibited distinct growth 
properties. Most young CAFCd35+ cells first generated cob-
blestones at day 21–28, and only 13% were first observed be-
yond 35 d. In contrast, old CAFCd35+ showed a significantly 
delayed response, with almost half (48%) generating no ob-
servable cobblestones until after 35 d and a sizeable fraction 
(12%) delayed until week 10 or later (Fig. 2 F).
Reduced functional HSC frequency  
in the LSK4834E+150+ population from old BM  
as measured by long-term limiting dilution transplantations
We  then  quantified  the  frequency  of  functional  HSCs 
within the LSK4834E+150+ populations from young and 
old donors by determining their ability to regenerate blood 
formation in a long-term limiting dilution transplantation 
assay.  We  injected  five  purified  LSK4834E+150+  cells 
from young or old donors into 63 and 143 young recipients, 
respectively (Fig. 3 A). From the proportions of recipients with 
significant (>1%) donor contribution to circulating granulo-
cytes (Gr-1+SSChi) at 24 wk after transplant (46/63 recipients 
of young cells and 65/143 recipients of old cells), we calcu-
lated the frequencies of functional HSCs in the starting popu-
lations  to  be  2.2-fold  lower  in  the  old  versus  young 
LSK4834E+150+ cells (26% vs. 12%; Fig. 3 B). However, 
considering the mean 12-fold increase in LSK4834E+150+ 
frequency in old mice (Fig. 1 D), this still represents a more 
than fivefold mean increase in the size of the functional HSC 
pool between 5 and 24 mo of age.
LSK48150+ cells from old mice have reduced short-term 
BM-homing efficiency
One possible explanation for the reduced in vivo functional 
frequency of old LSK4834E+150+ cells is that these cells 
exhibit an age-dependent change in their homing properties. 
The only previous study that tested the short-term homing 
efficiency between young and old HSCs (Liang et al., 2005) 
did so on a purely functional basis, by measuring the compet-
itive repopulating unit (CRU) content of whole BM before 
and after homing into irradiated recipients using secondary-
transplantation assays. Although this is a relevant and infor-
mative approach, it is limited in that it measures homed cells 
indirectly, using a second assay that itself is dependent on 
homing. To more directly and definitively measure whether 
changes in physical homing efficiency could be responsible 
for the effects observed here, we compared the short-term 
homing ability of purified cells from old and young mice 
(Fig. 4 A). To do this, we purified LSK48150+ cells from 
old and young mice transgenic for CFP, GFP, or dsRed, 
combined them at a known ratio, and injected them into 2696 Functional defects of aged murine HSCs | Dykstra et al.
Figure 3.  The old LSK4834E+150+ HSC pool is reduced in functional frequency and contains an increased proportion of myeloid-dominant HSCs 
with a lower output per HSC. (A) Summary of serial transplantation experiments designed to test lineage contribution ratio, overall blood cell output, and in vivo 
self-renewal properties of individual young and old HSCs. Data from primary (1°), secondary (2°), and tertiary (3°) recipients are presented in Figs. 3, 5, and 6, respec-
tively. (B) Five old or young LSK4834E+150+ cells were transplanted into 206 lethally irradiated young recipients, as described in Materials and methods. Positive 
recipients (46/63 young, 65/143 old) were defined as those with >1% donor contribution to circulating granulocytes (Gr-1+SSChi) at 24 wk after transplant, and 
functional HSC frequency was estimated via limiting dilution calculation. Calculated HSC frequencies were 1 in 3.8 and 1 in 8.3 for young and old LSK4834E+150+ 
cells, respectively. Error bars represent 95% confidence interval. ***, P < 0.001, likelihood ratio test. (C) Relative lineage contribution and overall donor contribution 
levels in all positive primary recipients. Positive recipients (46 young and 65 old) were classified as myeloid dominant, balanced, or lymphoid dominant based on the 
relative donor contribution ratio to circulating B, T, and myeloid cells at 24 wk after transplant, as described in Materials and methods. Each bar represents a positive 
mouse, and the red, blue, and yellow segments represent the relative donor contributions to the myeloid, B, and T lineages in the peripheral blood at 24 wk after 
transplant. Total donor contribution to the peripheral blood is indicated by the white dot for each mouse and is plotted using the logarithmic secondary y axis.  
Arrowheads indicate those primary recipients that were used as donors for secondary transplants. Asterisks indicate those primary recipients that were used as donors   
for secondary and tertiary transplants. (D and E) The mean contribution to total peripheral blood or to the granulocyte (Gr-1+SSChi) lineage was determined for 
myeloid-dominant (young n = 19, old n = 39) or balanced (young n = 25, old n = 20) primary recipients of young or old LSK4834E+150+ HSCs. To determine the 
donor chimerism per myeloid-dominant or balanced HSC, these mean contributions were corrected for differences in starting HSC frequency by dividing by the 
mean number of functional HSCs injected per positive recipient (1.79 HSCs per positive young recipient and 1.33 HSCs per positive old recipient). Time is indicated in 
weeks after transplant. Error bars represent 95% confidence intervals. All pairs were significantly different (***, P < 0.001) at the same time point between young and 
old for myeloid-dominant HSCs, and no significant differences were found for balanced HSCs (Mann-Whitney U test).JEM Vol. 208, No. 13 
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that excluded CD150 cells (Kent et al., 2009; Beerman et al., 
2010a; Morita et al., 2010) and a strict requirement for 
donor-derived granulocyte production at 24 wk after trans-
plant to score mice as positive.
Overall  repopulation  levels  per  repopulated  mouse 
were noticeably different between recipients of young and 
old donor HSCs, particularly in the recipients with myeloid-
dominant  donor  contributions.  Of  the  myeloid-dominant 
recipients of old HSCs, more than half (22 of 39) had overall 
donor contributions of <1% in the blood at 24 wk after trans-
plant, in contrast to only 2 of 19 such cases in recipients of 
young HSCs (Fig. 3 C). Even after correction for differences 
in the mean number of functional HSCs injected, the donor-
derived blood cell output per old myeloid-dominant HSC 
was found to be significantly reduced at all time points tested 
(Fig. 3 D). In contrast, there was no significant difference in 
overall output or granulocyte production between balanced 
HSCs from old or young donors (Fig. 3 E). These results 
clearly show that the myeloid-dominant HSCs that accumu-
late in old mice are functionally distinct from those that are 
present in young mice.
Old HSCs have decreased self-renewal activity and generate 
smaller daughter clones in extended serial transplants
Next, we performed secondary transplantations using cells 
from 58 primary recipients that had been transplanted with 
limiting dilutions of young or old HSCs to compare their 
self-renewal activity in vivo. At 10–12 mo after transplant, 
these primary recipients (identified by arrowheads in Fig. 3 C) 
were sacrificed, and 5 million unseparated BM cells were 
transplanted into pairs of secondary recipients. Positive sec-
ondary recipients were identified using the same stringent 
definition as was used for the primary recipients (>1% donor 
contribution to circulating Gr-1+SSChi granulocytes at 24 wk 
cells or overall donor cells in the blood. This decision was 
taken  to  ensure  that  any  cells  with  robust  self-renewal   
potential but lacking appreciable lymphoid differentiation   
potential, as have been reported to exist in both young (Dykstra 
et al., 2007; Morita et al., 2010) and old mice (Sudo et al., 
2000), would not be excluded.
It is important to note that although the primary recipi-
ents were injected with limiting dilutions of purified cells, 
they were not strictly equivalent to single-cell transplants 
because there is a certain likelihood that some positive mice 
were engrafted with multiple HSCs. Based on the estimated 
frequency obtained by limiting dilution calculations (Fig. 3 B), 
it could be expected that half of the positive mice trans-
planted with five young LSK4834E+150+ cells would have 
been clonally repopulated, 30% with two HSCs, and 20% 
with three or more HSCs. For the recipients of five old 
LSK4834E+150+ cells, >70% of positive recipients would 
be expected to have been clonally repopulated and only 6% 
with three or more HSCs.
First we compared the lineage distribution patterns of 
donor-derived blood cells in all positive primary recipients. To 
categorize the lineage distribution patterns, we calculated the 
ratio of the donor contribution to myeloid, B, and T lineage 
cells in each mouse at 24 wk after transplant. Using this ratio, 
we classified the outputs as myeloid dominant ( like), lym-
phoid dominant ( like), or balanced ( like; Fig. 3 C), ac-
cording to the terms previously assigned to similar definitions 
of these patterns (Dykstra et al., 2007). As expected (Dykstra 
et al., 2007; Cho et al., 2008; Beerman et al., 2010a), a bal-
anced lineage output was the most common pattern in the re-
cipients of young HSCs, whereas a myeloid-dominant lineage 
output was the most common pattern in the recipients of old 
HSCs. Lymphoid-dominant repopulation was rarely seen in 
this dataset. This is likely because of our use of a sorting strategy 
Figure 4.  LSK48150+ cells from old mice 
have reduced short-term marrow-homing 
efficiency compared with LSK48150+ cells 
from young mice. (A) Setup of short-term hom-
ing experiment. Shown here is a representative 
example (corresponding to experiment 2 in B).  
(B) Short-term BM-homing efficiency of old rela-
tive to young LSK48150+ cells. Results from six 
independent experiments are shown. In experi-
ments 4–6, more than two distinguishable donor 
cell types were transplanted simultaneously.  
(C) CAFC efficiency of young and old LSK48150+ 
cells before and after homing. 30–120 individual 
LSK48150+ cells from the old and young donors 
in B, either freshly isolated or isolated from the 
BM of short-term homing recipients, were seeded 
in stromal co-cultures and checked weekly for 
cobblestone areas. Shown is the mean proportion 
of single purified cells from 6 young mice and 11 
old mice that generated cobblestone areas at 
day 7 or later (CAFCd7+). Error bars indicate 95% 
confidence interval of the mean (CI). *, P < 0.05; 
***, P < 0.001, two-tailed Student’s t test.2698 Functional defects of aged murine HSCs | Dykstra et al.
primary and secondary transplantations and then repurified 
donor-derived HSCs and injected them at limiting dilu-
tions into tertiary recipients (Fig. 3 A). 16–24 wk later, the 
tertiary recipients were analyzed for donor-derived cells in 
the peripheral blood (Table II). Almost all positive tertiary 
recipients were myeloid dominant and had low levels of 
overall  chimerism,  reminiscent  of  the  myeloid-dominant 
HSCs that accumulate with age (Fig. 6). This demonstrates 
that HSCs with characteristics of those found in aged mice 
can be generated from normal young HSCs within the life-
time of a mouse.
DISCUSSION
Previous studies of aged B6 mice have reported numerous 
changes  in  the  HSC  compartment  compared  with  young 
mice. These include a dramatic increase in the proportion of 
BM cells with HSC markers and a concomitant decrease in 
function per purified HSC (Dykstra and de Haan, 2008). Our 
data extend these earlier findings, documenting a mean 
12-fold increase in LSK4834E+150+ cell frequency along 
with a 2.2-fold reduction in functional frequency when mea-
sured in a long-term transplantation assay. We also report 
that the age-related increase in the stem cell pool is highly 
variable between individual old mice, suggesting a possible 
loss of pool size control with age, yet appears to be indepen-
dent of the functional changes that were observed in the old 
stem cells themselves. We observed an approximately two-
fold decrease in the short-term homing ability of old as com-
pared with young LSK48150+ cells, suggesting that defects 
in homing may account for much of the decrease of simi-
lar magnitude in the in vivo functional frequency of old 
LSK4834E+150+ cells. A similar reduction was also ob-
served in the percentage of purified old cells with CAFC ac-
tivity in stromal cell–containing co-cultures, although old and 
young cells had equally high clonogenic efficiency in stroma-
free liquid cultures. The finding that these two properties 
were not shared by the same cells argues against the con-
cept  of  a  discrete  nonfunctional  subpopulation  in  old 
LSK4834E+150+ cells, as was suggested previously (Sudo 
et al., 2000). Rather, it favors a model in which all old 
LSK4834E+150+ cells (and by extension, all old HSCs) are 
reduced in their ability to respond to a variety of environmental 
cues. This reduced responsiveness could result in a reduced 
proportion of old LSK4834E+150+ cells that read out in any 
given assay and could also result in the cells that do read out 
in the assay exhibiting altered functional properties com-
pared with young HSCs. Our data are consistent with this 
model, as both quantitative and qualitative functional de-
fects  were  observed  when  old  LSK4834E+150+  cells 
were assayed in stromal co-cultures and in an in vivo trans-
plant setting.
An important unresolved question in the HSC aging field 
regards the developmental relationship between the HSC sub-
types seen in young mice and the myeloid-dominant HSCs 
that accumulate with age. Here, using clonal analyses of purified 
HSCs, we confirm a dramatic increase in aged mice of HSCs 
after transplant), and the presence of at least one positive sec-
ondary recipient was used as an indication that the originally 
transplanted HSC had extensive and long-term self-renewal 
activity in vivo. 20 of 20 mice transplanted with young HSCs 
successfully repopulated secondary recipients in this assay, com-
pared with only 24 of 38 mice transplanted with old HSCs. 
Notably, the old HSCs with limited self-renewal ability did 
not correlate with a particular lineage distribution pattern or 
overall repopulation level (Fig. 3 C and Table I). After cor-
recting for differences in the mean number of functional HSCs 
injected per primary recipient, the estimated proportion of 
primary HSCs with extensive self-renewal activity was deter-
mined to be 44% lower for old HSCs than young HSCs 
(Fig. 5 A). Repopulated secondary recipients of both old and 
young HSCs tended to recapitulate the lineage contribution 
pattern seen in primary recipients (Fig. 5 B). Furthermore, 
even after correcting for differences in the original HSC 
number injected, the output of blood cells per primary HSC 
in secondary recipients was found to be significantly lower 
when derived from old donor HSCs than from young HSCs. 
In contrast to the output in primary recipients (Fig. 3, D and 
E), the reduced blood cell output in secondary recipients was 
observed for all old HSCs, regardless of their original lineage 
contribution pattern (Fig. 5, C and D).
Cellular origins of aged HSCs
Finally, we wanted to gain insight into the origins of the 
low-output myeloid-dominant HSCs that accumulate with 
age. Specifically, we wondered whether these cells might arise 
from normal young HSCs or whether they are a unique 
type of epigenetically fixed HSCs present in young mice at 
low numbers but accumulating with age because of differ-
ences in proliferation or self-renewal. To answer this question, 
we aged young HSCs over 18–24 mo in vivo through   
Table I.  Summary of secondary transplant results
Age of original donor and 24-wk 
lineage contribution ratio in 
primary recipient
Proportion of successful 
secondary transplants
Young
Myeloid dominant 9 of 9
Balanced 9 of 9
Lymphoid dominant 2 of 2
Total 20 of 20
Old
Myeloid dominant 16 of 26
Balanced 8 of 11
Lymphoid dominant 0 of 1
Total 24 of 38
42–52 wk after transplant, BM was harvested from 20 primary recipients of young 
LSK4834E+150+ cells and 38 primary recipients of old LSK4834E+150+ cells as 
shown in Fig. 3 and injected into pairs of secondary recipients. Shown in the table 
are the success rates (i.e., one or both secondary recipients with >1% donor 
contribution to circulating Gr-1+SSChi cells at 24 wk) for secondary transplantations 
from primary recipients of old and young myeloid-dominant, balanced, and 
lymphoid-dominant HSCs.JEM Vol. 208, No. 13 
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primary recipients. This finding challenges the notion that the 
myeloid-dominant HSCs that accumulate with age are func-
tionally equivalent to those in young mice (Cho et al., 2008; 
Muller-Sieburg and Sieburg, 2008). However, it is conceiv-
able that a minor subset of young myeloid-dominant HSCs, 
functionally equivalent to the low-output myeloid-dominant 
HSCs in old mice, might expand with age (assuming they had 
a relative competitive advantage over the rest of the HSC pool). 
that  display  predominantly  myeloid  outputs.  However,  we 
show  that  these  myeloid-dominant  HSCs  exhibit  multiple 
functional defects as compared with young myeloid-dominant 
HSCs. It should be noted that in spite of their functional de-
fects,  these  cells  are  still  bona  fide  long-term  repopulating 
HSCs, as indicated by their continued production of short-
lived granulocytes at 6 mo after transplant, and their ability 
to successfully repopulate secondary recipients after 1 yr in 
Figure 5.  Old HSCs exhibit decreased self-renewal activity and smaller secondary clone size when measured by secondary transplantation  
in vivo. (A) After correcting for the differences in primary HSC frequencies, the proportion of primary HSCs with extensive in vivo self-renewal activity was 
calculated based on the secondary transplantation results shown in Table I. **, P < 0.01 for corrected proportions (Fishers exact test). Error bars represent 
corrected 95% confidence interval for original proportions. (B) All positive W41 secondary recipients and their corresponding primary recipients are 
shown. Colored bars and white dots represent relative donor lineage contribution and absolute donor proportion in the blood, as described for Fig. 3 C. 
Top panels show individual primary recipients, grouped by relative lineage contribution pattern as in Fig. 3 C. Bottom panels show the positive secondary 
recipients, arranged so that corresponding primary and secondary recipients are aligned vertically. l.d., lymphoid dominant. (C and D) The mean contribu-
tion to total peripheral blood or to the granulocyte lineage in secondary (2°) W41 recipients was calculated per primary (1°) young myeloid-dominant 
(n = 9), young balanced (n = 9), old myeloid-dominant (n = 13), or old balanced (n = 8) HSC by dividing by the mean number of functional HSCs injected per 
positive primary recipient (1.79 HSCs per positive young recipient and 1.33 HSCs per positive old recipient). Time is shown as weeks after transplant. Error 
bars represent 95% confidence intervals. *, P < 0.05; **, P < 0.01; ***, P < 0.001, Mann-Whitney U test.2700 Functional defects of aged murine HSCs | Dykstra et al.
enforced quiescence. However, the possible molecular iden-
tity of such an intrinsic control mechanism is completely un-
known and as such is currently limited only to speculation.
The possibility that HSC aging involves a somatic evolu-
tionary process driven by epigenetic alterations, DNA muta-
tions, and other potential sources of transmitted variability 
is also of interest. Because most somatic cells have a limited 
replicative lifespan, somatic evolution at the cell population 
level is thought to be largely restricted to stem cells (Pepper 
et al., 2007). Any HSCs with a slightly increased self-renewal 
ability, increased likelihood of quiescence, and/or decreased 
response to differentiation signals would tend to remain in 
the HSC compartment and accumulate there, assuming that 
these properties would be passed on to their cellular progeny. 
Conversely, HSCs with different characteristics would be lost. 
As aging progressed, selective pressures would continue to 
favor cells with self-renewal ability but not necessarily select 
for any of the other functional properties of HSCs. As a result, 
the size of the aged HSC pool would increase, and because of 
accumulating cellular damage, the functional potential of in-
dividual HSCs would decrease. Such cellular aging could thus 
be a driver of the selection process that ultimately results in 
the changes in HSC pool composition seen in aged mice. 
Further support of this concept has been provided from a 
mathematical modeling perspective, in which the accumula-
tion  of  division-dependent  changes  in  individual  cells  has 
been postulated to be the driving force behind HSC aging 
(Glauche et al., 2011).
A remaining unresolved question is why the HSCs that 
become prevalent in aging mice are preferentially myeloid 
dominant. It is tempting to speculate that some of the tran-
scriptional networks that are required for HSC self-renewal 
might overlap with myeloid cell production, in contrast to 
lymphoid cell production which can apparently be lost with-
out affecting self-renewal. One contributing factor to the 
prevalence of myeloid-dominant HSCs in old mice, shown 
here by our extended serial transplantation experiments, is 
that old myeloid-dominant HSCs do not appear to derive 
exclusively from young myeloid-dominant HSCs.
In support of this possibility, such HSCs have been reported to 
exist at low frequency in young mice (Morita et al., 2010) and 
were observed here also. An alternate possibility is that accu-
mulated DNA damage might be superimposed on the chang-
ing HSC pool over time, causing functional deficiencies within 
the fixed clonal subtypes (Rossi et al., 2007a; Beerman et al., 
2010a). In this study, we provide convincing evidence that 
HSCs undergo qualitative changes as they age by functionally 
assessing the progeny HSCs of normal young HSCs subjected 
to extended serial transplantations. From these experiments, we 
show  that  low-output  myeloid-dominant  HSCs  similar  to 
those that dominate the HSC compartment in old mice can 
be  derived  from  robust  young  myeloid-dominant or bal-
anced HSCs. This observation indicates that these functionally 
defective HSCs do not represent a fixed subtype and suggest 
that their accumulation with age is unlikely to be the exclusive 
result of their selective expansion from HSCs with similar prop-
erties that preexist at low frequency in young mice. Accumu-
lated DNA damage superimposed on specific HSC subtypes 
also seems unlikely. Rather, our findings support a model in 
which the functional defects characteristic of the HSCs that 
accumulate in old mice represent age-associated changes that 
affect the entire HSC pool. This might occur as part of a con-
trolled developmental program or as an end result of somatic 
evolution within the HSC pool.
The concept that HSC aging might be intrinsically con-
trolled is appealing because the qualitative changes observed in 
the aging HSC pool are generally consistent between indi-
vidual mice and appear to occur in a coordinated manner. 
Recently, Takizawa et al. (2011) reported that HSCs with ex-
tensive proliferative history were particularly prone to return 
to a quiescent state. They further speculated the existence of an 
intrinsic program that drives cells with high proliferative his-
tory toward quiescence. Such a program would explain the 
accumulation of phenotypic HSCs with age and may be di-
rectly related to the functional defects that we observe. Indeed, 
reduced readout in functional assays, delayed proliferation in 
stromal cultures, and a reduced clonal output of mature cells 
in vivo would all be consistent with a heightened degree of 
Table II.  Summary of tertiary transplant results
Secondary number Positive proportion of tertiary recipients transplanted with
100 LSK48150+ 40 LSK48150+ 20 LSK48150+
#1 0 of 0 0 of 0 0 of 4
#2 1 of 4 0 of 0 1 of 12
#3 1 of 9 0 of 3 4 of 26
#4 1 of 1 3 of 6 2 of 8
#5 2 of 6 0 of 0 4 of 9
#6 6 of 6 0 of 0 7 of 12
#7 8 of 8 3 of 3 5 of 15
6-12 mo after secondary transplantation of young LSK4834E+150+ cells, regenerated donor LSK48150+ cells were purified from selected positive secondary recipients 
(#1–#7) and injected at limiting dilutions (20, 40, or 100 cells) into tertiary recipients, as indicated in Fig. 3 and described in Materials and methods. Shown in the table are 
the proportion of tertiary transplanted animals in which continuing donor-derived hematopoiesis could be detected (>0.5% donor contribution to circulating Gr-1+SSChi 
granulocytes at 16-24 wk after transplant). Repopulation details of all positive tertiary recipients and the corresponding primary and secondary recipients are shown in Fig. 6.JEM Vol. 208, No. 13 
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Functional experiments of HSCs at a clonal level as de-
scribed in this study provide the high resolution that is neces-
sary  to  address  questions  about  the  underlying  process  of 
HSC aging and introduce increasing opportunities for new 
insights into the cellular and molecular mechanisms involved 
in the aging process. Exciting recent developments in purifi-
cation and assays for human HSCs (Notta et al., 2011) finally 
open up the possibility for similar interrogation of the aged 
human HSC pool at a clonal level. A better understanding of 
the biology and mechanisms of stem cell aging will help clar-
ify the relationship between the aged HSC pool and hemato-
logical  diseases  of  the  elderly  and  could  enable  targeted 
treatment strategies aimed to reduce or even reverse the aging 
process at the stem cell level as a strategy to combat aging and 
age-related pathologies.
MATERIALS AND METHODS
Mice. Young (4–5 mo) and old (24–26 mo) C57BL/6 (B6) mice were pur-
chased  from  Harlan  and  used  as  BM  donors.  Recipients  were  CD45.1 
C57BL/6.SJL (B6.SJL) mice obtained from Charles River or bred in-house. 
C57BL/6J-kitW-41J/kitW-41J (W41) mice were obtained from E. Dzerziak (Eras-
mus Medical Center, Rotterdam, Netherlands) and were crossed with B6.SJL 
to obtain CD45.1/5.2 W41 heterozygotes and further crossed to obtain CD45.1 
W41 homozygotes (W41.SJL). C57BL/6-Tg(CAG-EGFP)1Osb/J (GFP), B6.
Cg-Tg(CAG-DsRed*MST)1Nagy/J  (dsRed),  and  B6.129(ICR)-Tg(CAG-
ECFP)CK6Nagy/J (CFP) transgenic mice were purchased from the Jackson 
Laboratory and bred in-house. All experiments were approved by the Animal 
Experimentation Committee of the University Medical Center Groningen.
Purification and sorting of LSK4834E+150+ BM cells. Bones (fore and 
hind limbs, spine, pelvis, sternum, skull, and mandible) were harvested from 
individual young mice. Hind limbs and pelvises were harvested from individ-
ual old mice. After removal of soft tissue, bones were crushed with a mortar 
and pestle in lysis solution (NH4Cl) and passed through a 100-µm filter. Cells 
were washed with PBS + 0.2% BSA and then stained with CD34-FITC, 
EPCR-biotin, cKit-PE, Sca1–Pacific blue, CD150-PECy7, CD48–Alexa Fluor 
647, and Alexa Fluor 700–conjugated lineage antibodies B220, Gr-1, Mac-1, 
Ter119, CD3 (collectively, Lin–Alexa Fluor 700). After 45 min, cells were 
washed and secondary stained with streptavidin-conjugated APC-Cy7. After 
20 min, cells were washed again and resuspended in 1 µg/ml propidium iodide 
solution. Cells were double-sorted on a MoFlo Classical and/or MoFlo XDP cell 
sorter as follows: CD48LSK cells were enriched at high speed using “enrich” 
mode with a multiple droplet sort envelope, and then LSK4834E+150+ cells 
were resorted at low speed using “purify” mode into tubes for limiting dilution 
injections or “single cell” mode into 60 individual wells of a 96-well plate with 
preestablished stromal feeder layers for CAFC assay or into individual wells pre-
loaded with 200 µl of media for liquid cultures.
Single-cell CAFC assay. The single-cell CAFC assay was modified from   
de Haan et al. (1997). The FBMD stromal cell line (originally obtained from 
R. Ploemacher, Erasmus University, Rotterdam, Netherlands) was maintained 
in Quantum 333 complete fibroblast medium with l-glutamine (PAA Labo-
ratories) plus 104 mol/L -mercaptoethanol, 80 U/ml penicillin, and 80 µg/ml 
streptomycin at 37°C in a 5% CO2 incubator. FBMD cells were used to es-
tablish stromal cell layers in the inner 60 wells of 96-well microtiter plates and 
were subsequently incubated at 34°C for the entire culture period. Just before 
seeding with hematopoietic cells, media was replaced with 200 µl Iscove’s 
modified Dulbecco’s medium with GlutaMAX, 20% horse serum, 105 mol/l 
hydrocortisone, 104 mol/l -mercaptoethanol, 80 U/ml penicillin, and 
80 µg/ml streptomycin (collectively, CAFC media). Individual wells were then 
seeded with single purified cells using the single-cell deposition unit of a 
MoFlo cell sorter. Each week for up to 13 wk, wells were examined for the 
presence or absence of cobblestone areas (identified as colonies of at least five 
Figure 6.  Low-output myeloid-dominant repopulating cells can be 
generated from young HSCs in an extended serial transplantation set-
ting. 6–12 mo after transplant, regenerated donor LSK48150+ cells were puri-
fied from 10 positive secondary recipients, corresponding to 7 positive primary 
recipients (#1–#7). Purified cells were injected at limiting dilutions (20, 40, or 
100 cells) into tertiary recipients, as indicated in Fig. 3 and described in Table II 
and Materials and methods. Shown here is the donor repopulation kinetics in 
primary and secondary recipients, as well as all tertiary recipients in which con-
tinuing donor-derived hematopoiesis could be detected. Colored bars and white 
dots represent relative donor lineage contribution and absolute donor propor-
tion in the blood, as described for Fig. 3 C. The groups of four and three bars on 
the left represent donor blood cell output over time in the primary and second-
ary recipients, respectively. In cases where pairs of secondary recipients were 
tested (#2, #3, and #7), the secondary (2°) recipient bars represent the mean 
donor blood cell output in both secondary mice. The rightmost group of bars 
represent donor blood cell output in individual positive tertiary (3°) recipients at 
the time point of final analysis. nd, no donor derived cells detected.2702 Functional defects of aged murine HSCs | Dykstra et al.
Secondary transplantations of nonseparated BM. 59 primary recipients 
positive at 24 wk (20 recipients of five young cells and 39 recipients of five 
old cells) were sacrificed at 10–12 mo after transplant. Hind limbs were 
harvested, and bones were crushed with a mortar and pestle. Cells were 
counted, and 5 million BM cells were injected without competitor cells 
into pairs of recipients: one young B6.SJL recipient lethally irradiated with 
9.5 Gy and one young W41.SJL recipient sublethally irradiated with 3.5 Gy. 
8, 16, and 24 wk after transplantation, blood samples were collected and analyzed 
as in the primary recipients. Secondary recipients with >1% donor-derived 
Gr-1+SSChi cells at 24 wk after transplant were considered to be evidence for 
in vivo self-renewal ability in the primary clone.
Tertiary transplantations of donor-derived HSCs. 1–2 secondary re-
cipients from each of 7 selected primary recipients (10 secondary recipients 
in total) were sacrificed 6–12 mo after transplant, and hind limbs and pel-
vises were harvested. BM cells obtained by crushing were washed with 
PBS  +  0.2%  BSA  and  then  stained  with  cKit-PE,  Sca1–Pacific  blue, 
CD48–Alexa Fluor 647, and Lin–Alexa Fluor 700. CD48LSK cells were 
presorted  and  then  restained  with  additional  antibodies  to  CD45.2-
  PerCPCy5.5, CD45.1-PECy7, CD150-FITC, and DAPI as a viability stain. 
CD45.2+CD45.1CD48CD150+LSK cells were then sorted into tubes 
for tertiary transplantations. Dilutions of 20, 40, and/or 100 donor-derived 
CD45.2+CD45.1CD48CD150+LSK  cells  from  each  of  seven  donors 
were injected into a total of 132 tertiary recipients (58 lethally irradiated 
B6.SJL [CD45.1] recipients receiving 1.5 million W41.SJL radioprotec-
tive cells and 74 sublethally irradiated W41.SJL recipients without radio-
protective cells).
Short-term homing experiments. Bones (fore and hind limbs, spine, 
pelvis, and sternum) were harvested from individual old (27–28 mo) and 
groups of two young (2.5–3.5 mo) CFP, GFP, or dsRed mice, some of 
which had been crossed several generations with B6.SJL to acquire the 
CD45.1 allele. BM cells were obtained by crushing and were stained with 
CD150-PECy7, CD48–Alexa Fluor 647, Lin–Alexa Fluor 700, cKit-PE or 
cKit–FITC, and Sca1–Pacific blue or Sca1-FITC. LSK cells were pre-
sorted using a MoFlo Classical, and CFP+, GFP+, or dsRed+ LSK48150+ 
cells  were  then  resorted  using  a  MoFlo  XDP.  Single  young  or  old 
GFP+LSK48150+  cells  were  sorted  into  individual  wells  of  96-well 
CAFC plates. The remaining cells (0.3–1.0 × 104 young and 0.7–4.4 × 104 
old LSK48-150+ cells) were combined at known ratios and injected into 
a single 2–3-mo-old B6 recipient irradiated 24 h previously with 9.5 Gy 
from a 137Cs source. 16–21 h later, the recipient mouse was sacrificed, and 
bones  (fore  and  hind  limbs,  spine,  pelvis,  and  sternum)  were  harvested, 
crushed, and stained with CD45.1–Alexa Fluor 647, CD45.2-PECy7, and 
propidium  iodide.  The  ratio  of  homed  CFP+,  GFP+  and/or  dsRed+ 
CD45.1+ or CD45.2+ cells was measured and compared with the ratio of 
the injected cells to determine the relative homing efficiency. In addition, 
single cells of each homed type were seeded into individual wells of 96-well 
CAFC plates to compare the function of the homed cells with the freshly 
isolated starting population.
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flat nonrefractile cells growing underneath the stromal layer) using 100 mag-
nification on an inverted microscope. Media was also refreshed weekly by re-
moving most of the old media with a suction pipette (without disturbing the 
stromal layer) and adding 180 µl of fresh CAFC media.
Single-cell  liquid  cultures.  60–120  purified  LSK4834E+150+  or 
LSK48150+ cells from each of five young or six old mice were individually 
seeded using the single-cell deposition unit of a MoFlo cell sorter into sepa-
rate wells of round-bottom 96-well plates containing 200 µl StemSpan 
media (STEMCELL Technologies) supplemented with 10% FCS, 300 ng/ml of 
stem cell factor, and 20 ng/ml IL-11. Plates were incubated at 37°C, and 
13–14 d later, wells were scored for the presence or absence of a clone of at 
least 5,000 cells. The proportion of wells containing such clones is reported 
as the clonogenic efficiency in liquid culture. Note that wells were not 
checked for the presence or absence of a starting cell, so all wells were as-
sumed to have received one cell.
Limiting dilution transplantations and determination of lineage bias. 
60 LSK4834E+150+ cells from individual young or old B6 (CD45.2) mice 
were sorted into 600 µl PBS supplemented with 5% FCS. 6 × 106 whole BM 
cells from CD45.1/5.2 W41 heterozygous mice were added as radioprotec-
tive/competitor cells, and total volume was adjusted to 1.2 ml. 100 µl of the 
resulting cell mixture was injected retroorbitally into groups of up to 10 young 
B6.SJL (CD45.1) recipients that were lethally irradiated (9.5Gy) 24–30 h pre-
viously. In this way, each recipient was transplanted with a mean of five puri-
fied cells plus 5 × 105 radioprotective/competitor cells. At specified times after 
transplantation, blood samples were obtained via retroorbital puncture. Eryth-
rocytes were lysed with ammonium chloride solution, and the remaining cells 
were  stained  with  CD45.1-PE,  CD45.2–Pacific  blue,  B220-FITC,  CD3-
APC, Gr-1–PECy7, and Mac-1–Alexa Fluor 700. Cells were washed and re-
suspended in 1 µg/ml propidium iodide solution and analyzed on an LSR-II 
(BD). Recipients with >1% donor-derived contribution to Gr-1+SSChi cells at 
24 wk after transplant were considered to be repopulated with HSCs and were 
counted as positive for the purposes of the limiting dilution calculation, per-
formed using the Web-based calculator provided at http://bioinf.wehi.edu 
.au/software/elda/ (Hu and Smyth, 2009). Relative lineage contribution ratio 
was determined as follows: A minimum of 100,000 events were collected for 
each blood sample. Doublets, dead cells, erythrocytes, and debris were ex-
cluded using appropriate gates. Myeloid cells were defined as Gr-1– and/or 
Mac-1–positive events that were negative for CD3 and B220. T cells were 
defined as CD3-positive events that were negative for B220, Gr-1, and Mac-1. 
B cells were defined as B220-positive events that were negative for CD3, Gr-1, 
and Mac-1. The proportion of myeloid (GM), B, and T cells that were donor 
derived was then determined using CD45.1 versus CD45.2 for each cell 
type. The donor proportion of each lineage was then plotted relative to 
each other in a 100% stacked bar graph. Thus, a perfectly balanced donor 
clone (e.g., contributing 50% of all circulating T cells, 50% of all circulating 
B cells, and 50% of all circulating myeloid cells in that mouse) would show 
exactly one-third of the stacked bar for each lineage. The total donor chi-
merism was determined by dividing the sum of the donor myeloid, B, and 
T cells by the sum of all myeloid, B, and T cells. Lymphoid-dominant, 
myeloid-dominant, and balanced HSCs were retrospectively identified by 
the GM/(B + T) donor contribution ratio at 24 wk after transplant. A 
GM/(B + T) ratio of <0.25 indicated a lymphoid-dominant HSC, a GM/ 
(B + T) ratio of >2 indicated a myeloid-dominant HSC, and a GM/(B + T) ratio 
between 0.25 and 2 indicated a balanced HSC. Note that the strategy used 
here is identical to previously described criteria used to identify -, -, -, 
and -LTRCs (Dykstra et al., 2007), with two important differences. First, 
instead of measuring the relative lineage contribution at 16 wk after trans-
plant, we used 24 wk after transplant to determine this ratio. Second, instead 
of >1% donor-derived cells in the blood at 16 wk after transplant to define a 
positive recipient, we used >1% donor-derived Gr-1+SSChi cells at 24 wk 
after transplant. The criteria used here exclude most or all repopulating cells 
lacking robust self-renewal potential in young mice (i.e., - and -LTRCs; 
Dykstra et al., 2007).JEM Vol. 208, No. 13 
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